Narrow search
Showing 1 - 10 of 717
Cover Image
Chinese Capital Market : An Empirical Overview
Hu, Grace Xing - 2018
and is now the second largest in the world. Due to China's tight capital controls, the development of its capital market … bound to change substantially as China becomes more integrated into the global financial system. In this paper, we provide …
Persistent link: https://www.econbiz.de/10012926413
Cover Image
Initial Public Offering and Corporate Governance in China's Transitional Economy
Chen, Chien-Hsun - 2010
that the only industries in which listed companies in China display strong performance are public utilities, transportation …
Persistent link: https://www.econbiz.de/10012762840
Cover Image
The SOE Premium and Government Support in China's Credit Market
Geng, Zhe - 2019
We study how perceived government support for state-owned enterprises (SOEs), can shut out non-SOEs in China's credit … label. Examining the real impact of this deepening allocational inefficiency, we find that, since 2018Q2, non-SOEs in China …
Persistent link: https://www.econbiz.de/10012857737
Cover Image
The Global History of Corporate Governance : An Introduction
Steier, Lloyd - 2013
This paper presents a synopsis of recent NBER studies of the history of corporate governance in Canada, China, France …
Persistent link: https://www.econbiz.de/10012754560
Cover Image
Ownership and Control in Outsourcing to China : Estimating the Property-Rights Theory of the Firm
Feenstra, Robert C.; Hanson, Gordon H. - 2021
In this paper, we develop a simple model of international outsourcing and apply it to processing trade in China. We … observe China's processing exports broken down by who owns the plant and by who controls the inputs the plant processes …. Multinational firms engaged in export processing in China tend to split factory ownership and input control with managers in China …
Persistent link: https://www.econbiz.de/10013228044
Cover Image
Bundling Among Rivals : A Case of Pharmaceutical Cocktails
Lucarelli, Claudio - 2010
We empirically analyze the welfare effects of cross-firm bundling in the pharmaceutical industry. Physicians often treat patients with "cocktail" regimens that combine two or more drugs. Firms cannot price discriminate because each drug is produced by a different firm and a physician creates the...
Persistent link: https://www.econbiz.de/10013138761
Cover Image
Pricing and Reimbursement in U.S. Pharmaceutical Markets
Berndt, Ernst R. - 2010
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10013139118
Cover Image
Has the European Union Achieved a Single Pharmaceutical Market?
Timur, Aysegul - 2010
This paper explores price differences in the European Union (EU) pharmaceutical market, the EU's fifth largest industry. With the aim of enhancing quality of life along with industry competitiveness and R&D capability, many EU directives have been adopted to achieve a single EU-wide...
Persistent link: https://www.econbiz.de/10013139285
Cover Image
What Does Health Reform Mean for the Healthcare Industry? Evidence from the Massachusetts Special Senate Election
Al-Ississ, Mohamad - 2010
The recent reform of the U.S. health care system has been described both as a boon and a death blow for the healthcare industry and for private insurers in particular. We exploit the surprise election of Republican Scott Brown to the U.S. Senate, which dealt a serious blow to the prospects for...
Persistent link: https://www.econbiz.de/10013140997
Cover Image
Cross-National Evidence on Generic Pharmaceuticals : Pharmacy vs. Physician-Driven Markets
Danzon, Patricia M. - 2011
This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...
Persistent link: https://www.econbiz.de/10013122264